Inhalation Sciences wins new Purchase Order from Asian distributor worth 94,000 USD

Inhalation Sciences AB (ISAB) has received a new Purchase Order worth 94,000 USD, or just over 1 million SEK, from a distributor in Asia, the second order from the region in a week. The order includes in vitro modules for inhaled drug development.ISAB has received a new order for its in vitro technology from a regional distributor in Asia worth 94,000 USD. It is the second order from the region in one week. Investment and innovation in inhaled therapies has increased significantly in Asia-Pacific over recent years. In September 2022, for example, China approved the world’s first inhaled